A Phase II Study of Double Induction Chemotherapy for Newly Diagnosed Non-L3 Adult Acute Lymphoblastic Leukemia With Investigation of Minimal Residual Disease and Risk of Relapse Following Maintenance Chemotherapy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Folinic acid; Mercaptopurine; Methotrexate; Mitoxantrone; Pegaspargase; Prednisone; Tioguanine; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 25 Mar 2015 Biomarkers information updated
- 22 Aug 2012 Planned end date changed from 1 Feb 2009 to 1 Nov 2014 as reported by ClinicalTrials.gov.
- 27 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.